Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Antoni TorresMOTIV (MOxifloxacin Treatment IV) Study Group

Abstract

The aim of this study was to show that sequential intravenous and oral moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a combination regimen (intravenous ceftriaxone, 2 g once per day, plus sequential intravenous and oral levofloxacin, 500 mg twice per day) in patients hospitalized with community-acquired pneumonia. We conducted a prospective, multicenter, randomized, double-blind noninferiority trial. Patients with a Pneumonia Severity Index (PSI) of III-V were stratified on the basis of PSI risk class before randomization. The primary efficacy end point was clinical response at test of cure (4-14 days after the completion of treatment). Secondary efficacy end points were clinical and bacteriological response at end of treatment (days 7-14) and at follow-up assessment (21-28 days after the end of treatment), overall mortality, and mortality attributable to pneumonia. Seven hundred thirty-three patients were enrolled in the study (368 in the moxifloxacin arm and 365 in the comparator arm); 49% had a PSI of IV, and 10% had a PSI of V. Of 569 patients (291 in the moxifloxacin arm and 278 in the comparator arm) valid for per-protocol analysis, the overall clinical cure rates at test of cure were 86.9% ...Continue Reading

References

May 1, 1993·American Journal of Epidemiology·C JokinenS Soimakallio
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Feb 7, 2003·The European Respiratory Journal·A TorresG Höffken
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fernando J Martinez
Dec 18, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G HoeffkenD Church
Dec 29, 2004·International Journal of Antimicrobial Agents·José Manuel Querol-RibellesIsidoro Martínez
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tobias WelteUNKNOWN MOXIRAPID Study Group
Dec 2, 2005·The European Respiratory Journal·M WoodheadUNKNOWN European Society of Clinical Microbiology and Infectious Diseases
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antonio AnzuetoUNKNOWN Community-Acquired Pneumonia Recovery in the Elderly Study Group
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society

❮ Previous
Next ❯

Citations

May 3, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T Welte
Aug 21, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Prasanta Raghab MohapatraAshok K Janmeja
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ines Zollner-SchwetzRobert Krause
Sep 20, 2011·The Journal of Antimicrobial Chemotherapy·Pieter-Jan CortoosGert Laekeman
Mar 12, 2009·Current Opinion in Pulmonary Medicine·Mateo Cabre
Apr 24, 2009·Current Opinion in Pulmonary Medicine·Sergio CarbonaraGioacchino Angarano
May 12, 2010·International Journal of Clinical Practice·T E AlbertsonM S Niederman
Jul 5, 2011·Drugs & Aging·Ulrich ThiemLudger Pientka
Jul 11, 2012·Mediators of Inflammation·Helen C SteelCharles Feldman
Dec 20, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T AvniM Paul
May 3, 2014·International Journal of Antimicrobial Agents·Hartmut M Lode
Jan 22, 2009·Der Internist·T Welte
Apr 14, 2011·Expert Opinion on Emerging Drugs·Vicenç FalcóJordi Rello
Jan 2, 2013·Medicina clínica·Antoni TorresUNKNOWN Grupo de la Guía Multidisciplinar para el Manejo de la Neumonía Adquirida en la Comunidad
Sep 14, 2010·Archivos de bronconeumología·Rosario MenéndezUNKNOWN Sociedad Española de Neumología y Cirugía Torácica
Sep 16, 2015·Critical Care : the Official Journal of the Critical Care Forum·Simone GattarelloJordi Rello
Feb 18, 2015·Journal of the American Geriatrics Society·Tomer AvniMical Paul
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Marc Miravitlles, Antonio Anzueto
Aug 19, 2011·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Koichiro YoshidaYoshihito Niki
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Dec 15, 2015·Therapeutic Advances in Respiratory Disease·Fumitaka ItoShinya Minatoguchi
Oct 14, 2017·European Journal of Clinical Investigation·Konstantinos Z VardakasMatthew E Falagas
Jul 4, 2018·Infection & chemotherapy·Mi Suk LeeSungmin Kiem
Sep 8, 2018·Expert Opinion on Drug Safety·Fahadullah KhanZahid Ali
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre-Francois Laterre
Jul 23, 2009·Expert Review of Anti-infective Therapy·Daniel J Niven, Kevin B Laupland
Aug 18, 2009·Expert Review of Anti-infective Therapy·Olaf Burkhardt, Tobias Welte
Mar 12, 2009·Current Opinion in Infectious Diseases·Charles Feldman, Ronald Anderson
May 8, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Françoise Van Bambeke, Paul M Tulkens
Nov 16, 2010·Expert Review of Anti-infective Therapy·Brian Wispelwey, Katherine R Schafer
Jun 11, 2019·Expert Review of Anti-infective Therapy·João Paulo TellesFelipe Francisco Tuon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Shuyun XuWeining Xiong
© 2022 Meta ULC. All rights reserved